A new BCR-ABL1 <i>Drosophila</i> model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia
Roberto Bernardoni(University of Bologna), Daniela Cilloni(University of Turin)
Cited by 9
Related Papers
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
|Journal of Clinical Oncology|2013|168
Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms
|Journal of Cellular and Molecular Medicine|2020|33
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells
|International Journal of Molecular Sciences|2023|16